EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway

Junming Xu, Xiaopu Sang, Yongfei He, Jie Ke, Jiasen Xu, Tanbin Liu, Jicai Wang, Hang Zhai, Xiaoni Chen, Xianjie Shi, Fenfang Wu

Frontiers in Pharmacology · 25.11.2025 · 16

DOI: 10.3389/fphar.2025.1730255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.11.2025. Verfasst von Junming Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver fibrosis, driven by excessive extracellular matrix (ECM) deposition and activation of hepatic stellate cells (HSCs), still lacks effective therapies, partly due to the absence of human-relevant models. Lycii Radicis Cortex (LRC), a traditional Chinese medicine, exhibits reported anti-inflammatory and antioxidant activities, yet its anti-fibrotic potential has not been validated in human organoid-based systems.

Methods

We established hiPSC-derived multilineage hepatobiliary organoids (mHBOs) containing mesoderm-derived HSCs and implemented a TGF-β–induced fibrosis model within this platform. Using mHBOs alongside a CCl4-injury mouse model, we assessed the anti-fibrotic activity of LRC, and investigated underlying mechanisms.

Results

LRC significantly attenuated fibrosis in mHBOs and in CCl 4 -injured mice, reducing ECM accumulation and HSC activation. In mHBOs, LRC activated the cAMP–PKA–CREB pathway, thereby suppressing HSC activation and reducing parenchymal apoptosis; these effects were reversed by PKA inhibition.

Conclusion

LRC exhibits potent anti-fibrotic activity in a physiologically relevant human organoid model, providing mechanistic insight into HSC regulation and supporting its potential as a candidate therapy for chronic liver disease. Furthermore, this study introduces a translational platform integrating animal models and hiPSC-derived organoids to facilitate anti-fibrotic drug discovery and evaluation.

Schlagwörter

Stichwörter der Autor:innen

IPSCs (induced pluripotent stem cells)cAMP–PKA–CREB pathwayliver fibrosislycii radicis cortexnatural productsorganoid

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
  • Biotherapy Center, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
  • Department of Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China.
  • School of traditional Chinese medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
  • Hubei Shizhen Laboratory, Wuhan, Hubei, China.

Zitieren

APA

Xu, J., Sang, X., He, Y., Ke, J., Xu, J., Liu, T., Wang, J., Zhai, H., Chen, X., Shi, X., & Wu, F. (2025). Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1730255

Vancouver

Xu J, Sang X, He Y, Ke J, Xu J, Liu T, et al. Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1730255

BibTeX
@article{Xu2025,
  author = {Xu, Junming and Sang, Xiaopu and He, Yongfei and Ke, Jie and Xu, Jiasen and Liu, Tanbin and Wang, Jicai and Zhai, Hang and Chen, Xiaoni and Shi, Xianjie and Wu, Fenfang},
  title = {Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1730255}
}
Kostenlos starten →